user

Discoveries

Roche’s injectable PD-L1 inhibitor granted FDA approval for multiple cancer types

Roche’s injectable PD-L1 inhibitor Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) has been approved by the US Food and Drug Administration (FDA) for multiple cancer types. The...

Advances

Latest Innovations in Medical Robotics

The robots assist surgeons in performing minimally invasive surgeries with enhanced precision, skill, and control. Source link

Discoveries

Genentech’s new multiple sclerosis treatment reduces admin time

Genentech’s newly approved multiple sclerosis (MS) injection takes about 10 minutes to administer, dramatically reducing the four to six hours required by its intravenous...

Advances

AI cameras could help identify life threatening infections

When you buy through links on our articles, Future and its syndication partners may earn a commission.Viruses such as the common cold make up...

Discoveries

ESMO24: A cancer cachexia drug, VEGF enthusiasm and immunotherapy’s survival impact

Advances

FDA Commissioner Talks Healthcare AI

InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Healthcare AI startups developing products geared towards hospital...

Discoveries

Trastuzumab Deruxtecan Significantly Outperforms C

BYLINE: Denise Heady Newswise — A new study published in NEJM and led by global principal investigator Aditya Bardia, MD, director of Translational Research Integration...

1...269270271...1,050 Page 270 of 1,050

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Global

user

About Us

Latest

Popular

Sitemap